Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCUL Ocular Therapeutix

休市中 05-09 16:00:00 EDT

7.06

-0.39

-5.23%

盘后7.06

+0.000.00%

19:41 EDT

最高7.56	最低7.02	成交量119.16万
今开7.46	昨收7.45	日振幅7.25%
总市值11.25亿	流通市值8.77亿	总股本1.59亿
成交额855.05万	换手率0.96%	流通股本1.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCUL","market":"US","secType":"STK","nameCN":"Ocular Therapeutix","latestPrice":7.06,"timestamp":1746820800000,"preClose":7.45,"halted":0,"volume":1191637,"hourTrading":{"tag":"盘后","latestPrice":7.06,"preClose":7.06,"latestTime":"19:41 EDT","volume":31987,"amount":225828.894,"timestamp":1746834112337},"delay":0,"floatShares":124245669,"shares":159299736,"eps":-1.150079,"marketStatus":"休市中","change":-0.39,"latestTime":"05-09 16:00:00 EDT","open":7.46,"high":7.56,"low":7.02,"amount":8550472.1298,"amplitude":0.072483,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.150079,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1406260800000,"exchange":"NASDAQ","adjPreClose":7.45,"postHourTrading":{"tag":"盘后","latestPrice":7.06,"preClose":7.06,"latestTime":"19:41 EDT","volume":31987,"amount":225828.894,"timestamp":1746834112337},"volumeRatio":0.5506952473115763,"impliedVol":0.922,"impliedVolPercentile":0.736},"requestUrl":"/m/hq/s/OCUL","defaultTab":"news","newsList":[{"id":"2534426257","title":"Ocular Therapeutix, Inc.2025财年第一财季实现净利润-64.05百万美元，同比增加1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534426257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534426257?lang=zh_cn&edition=full","pubTime":"2025-05-11 00:01","pubTimestamp":1746892877,"startTime":"0","endTime":"0","summary":"5月11日，Ocular Therapeutix, Inc.公布财报，公告显示公司2025财年第一财季净利润为-64.05百万美元，同比增加1.23%；其中营业收入为10.70百万美元，同比减少27.56%，每股基本收益为-0.38美元。从资产负债表来看，Ocular Therapeutix, Inc.总负债1.40亿美元，其中短期债务2.16百万美元，资产负债比为2.90，流动比率为0.11。机构评级：截至2025年5月11日，当前有13家机构对Ocular Therapeutix, Inc.目标价做出预测，其中目标均价为17.46美元，其中最低目标价为14.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250511000335a479610b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250511000335a479610b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL"],"gpt_icon":0},{"id":"2534457897","title":"Ocular Therapeutix, Inc.盘中异动 大幅跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534457897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534457897?lang=zh_cn&edition=full","pubTime":"2025-05-10 03:18","pubTimestamp":1746818309,"startTime":"0","endTime":"0","summary":"北京时间2025年05月10日03时18分，Ocular Therapeutix, Inc.股票出现异动，股价急速下跌5.10%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为3.49%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Osr Holdings Inc C/Wts 09/02/2028 、Phathom Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Polyrizon Ltd.、Pasithea Therapeutics Corp.较为活跃，换手率分别为2129.37%、175.42%、61.92%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Geovax Labs Inc C/Wts 29/09/2025、Liminatus Pharma Inc C/Wts 30/04/2030 ，振幅分别为150.95%、96.73%、65.30%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051003182994f21207&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051003182994f21207&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2533592386","title":"Ocular Therapeutix, Inc.盘中异动 早盘大幅下跌5.14%报7.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533592386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533592386?lang=zh_cn&edition=full","pubTime":"2025-05-06 23:07","pubTimestamp":1746544030,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日23时07分，Ocular Therapeutix, Inc.股票出现波动，股价急速跳水5.14%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为4.31%。其相关个股中，Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃，换手率分别为6709.06%、1125.10%、394.23%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为126.06%、42.31%、39.11%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506230711aa2c849c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506230711aa2c849c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2533258764","title":"Ocular Therapeutix, Inc.盘中异动 快速下跌9.15%报8.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533258764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533258764?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:31","pubTimestamp":1746451882,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时31分，Ocular Therapeutix, Inc.股票出现波动，股价快速下挫9.15%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nucana Plc、Scisparc Ltd.涨幅较大，Nucana Plc、Scisparc Ltd.、Aptevo Therapeutics Inc.较为活跃，换手率分别为671.53%、252.92%、42.90%，振幅较大的相关个股有Polyrizon Ltd.、Nucana Plc、Scisparc Ltd.，振幅分别为12.89%、12.17%、11.76%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213122a6d3e10e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213122a6d3e10e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2530281372","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.06%报8.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530281372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530281372?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:52","pubTimestamp":1745848346,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时52分，Ocular Therapeutix, Inc.股票出现波动，股价快速拉升5.06%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Portage Biotech Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1761.06%、351.89%、66.69%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Senti Biosciences, Inc.、Protara Therapeutics, Inc.，振幅分别为27.39%、22.80%、22.69%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821522694e5f950&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821522694e5f950&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2529559972","title":"Ocular Therapeutix, Inc.盘中异动 下午盘股价大涨5.12%报8.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529559972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529559972?lang=zh_cn&edition=full","pubTime":"2025-04-23 03:29","pubTimestamp":1745350186,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日03时29分，Ocular Therapeutix, Inc.股票出现波动，股价大幅拉升5.12%。截至发稿，该股报8.00美元/股，成交量58.2135万股，换手率0.37%，振幅4.20%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.95%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423032946a462daff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423032946a462daff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2527230142","title":"Ocular Therapeutix, Inc.盘中异动 早盘股价大跌5.05%报7.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527230142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527230142?lang=zh_cn&edition=full","pubTime":"2025-04-16 23:06","pubTimestamp":1744815960,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日23时06分，Ocular Therapeutix, Inc.股票出现波动，股价急速下跌5.05%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为1.04%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Briacell Therapeutics Corp.、Transcode Therapeutics, Inc.、Pmgc Holdings Inc.较为活跃，换手率分别为487.54%、176.22%、172.49%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Dermata Therapeutics Inc C/Wts 、Jupiter Neurosciences, Inc.，振幅分别为89.52%、36.67%、32.76%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416230600a6bcb781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416230600a6bcb781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2518440695","title":"Ocular Therapeutix, Inc.2024财年实现净利润-1.94亿美元，同比减少140.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518440695?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449669,"startTime":"0","endTime":"0","summary":"3月9日，Ocular Therapeutix, Inc.公布财报，公告显示公司2024财年净利润为-1.94亿美元，同比减少140.28%；其中营业收入为63.72百万美元，同比增加9.03%，每股基本收益为-1.22美元。从资产负债表来看，Ocular Therapeutix, Inc.总负债1.43亿美元，其中短期债务1.93百万美元，资产负债比为3.21，流动比率为0.11。机构评级：截至2025年3月9日，当前有10家机构对Ocular Therapeutix, Inc.目标价做出预测，其中目标均价为17.90美元，其中最低目标价为14.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230abef9832&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000230abef9832&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL"],"gpt_icon":0},{"id":"2517543948","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517543948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517543948?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:43","pubTimestamp":1741185809,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时43分，Ocular Therapeutix, Inc.股票出现波动，股价大幅上涨5.23%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为447.21%、265.62%、205.52%，振幅较大的相关个股有Silexion Therapeutics Corp、Aditxt, Inc.、Radiopharm Theranostics Limited，振幅分别为25.23%、23.90%、23.49%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224329abe9b4a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224329abe9b4a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2517606781","title":"Ocular Therapeutix, Inc.盘中异动 早盘快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517606781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517606781?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:28","pubTimestamp":1741102080,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时28分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.15%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1175.00%、1136.55%、697.38%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为100.00%、70.63%、66.67%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232800abe80038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232800abe80038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2516321672","title":"Citizens Capital Markets：维持Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价由22.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516321672","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516321672?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:22","pubTimestamp":1741098129,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：维持Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价由22.00美元调整至19.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04222248521892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OCUL"],"gpt_icon":0},{"id":"2516796634","title":"Ocular Therapeutix, Inc.盘中异动 早盘大幅下跌5.74%报6.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516796634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516796634?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:44","pubTimestamp":1741013071,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时44分，Ocular Therapeutix, Inc.股票出现异动，股价大幅跳水5.74%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Aldeyra Therapeutics, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Entero Therapeutics Inc.、Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为99.66%、52.66%、43.38%，振幅较大的相关个股有Entero Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为55.45%、24.83%、22.27%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224431abe6377b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224431abe6377b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2516268034","title":"Ocular Therapeutix(OCUL.US)：2024年Q4财报实现营收1708.3万美元，前值为1480.2万美元，预期值为1689万美元；每股收益为-0.29美元，前值为-0.35美元，预期值为-0.22美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516268034","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516268034?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:13","pubTimestamp":1741003981,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix(OCUL.US)：2024年Q4财报实现营收1708.3万美元，前值为1480.2万美元，预期值为1689万美元；每股收益为-0.29美元，前值为-0.35美元，预期值为-0.22美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03201348492142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OCUL"],"gpt_icon":0},{"id":"1133495113","title":"Ocular Therapeutix公司2024年第四季度GAAP每股收益$(0.29) 不及预期$(0.24), 销售额$1708万 不及预期$1720万","url":"https://stock-news.laohu8.com/highlight/detail?id=1133495113","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133495113?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:10","pubTimestamp":1741003823,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix报告其季度每股亏损为$，低于分析师普遍预期的$，差异为20.83%。与去年同期每股亏损$相比，这一数字增加了17.14%。该公司报告季度销售额为1708万美元，低于分析师普遍预期的1720万美元，差异为0.71%。以上内容来自Benzinga Earnings专栏，原文如下：$Ocular Therapeutix$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 20.83 percent. This is a 17.14 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $17.08 million which missed the analyst consensus estimate of $17.20 million by 0","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Ocular Therapeutix公司2024年第四季度GAAP每股收益$(0.29) 不及预期$(0.24), 销售额$1708万 不及预期$1720万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2509785598","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.04%报7.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509785598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509785598?lang=zh_cn&edition=full","pubTime":"2025-02-07 03:37","pubTimestamp":1738870629,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日03时37分，Ocular Therapeutix, Inc.股票出现波动，股价急速下跌5.04%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Transcode Therapeutics, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为6930.13%、1744.72%、179.03%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为125.58%、69.09%、64.30%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033710987cb9d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033710987cb9d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2509235336","title":"Ocular Therapeutix, Inc.盘中异动 大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509235336?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:50","pubTimestamp":1738770656,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时50分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.00%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4112.35%、1233.08%、1082.07%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502052350569619176f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502052350569619176f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2503640182","title":"Ocular Therapeutix, Inc.盘中异动 急速拉升5.09%报8.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503640182?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951541,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Ocular Therapeutix, Inc.股票出现波动，股价大幅上涨5.09%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.07%、53.26%、35.43%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Eterna Therapeutics Inc.，振幅分别为14.29%、12.00%、11.55%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223222a222fe17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223222a222fe17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2503865686","title":"Ocular Therapeutix, Inc.盘中异动 快速下挫5.05%报7.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503865686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503865686?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:10","pubTimestamp":1736885433,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时10分，Ocular Therapeutix, Inc.股票出现异动，股价快速跳水5.05%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为1.23%。其相关个股中，Eterna Therapeutics Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1084.20%、603.99%、421.77%，振幅较大的相关个股有Eterna Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.，振幅分别为170.74%、146.24%、69.81%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115041033a221ff6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115041033a221ff6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2503826815","title":"Ocular Therapeutix, Inc.盘中异动 急速跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503826815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503826815?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:00","pubTimestamp":1736784018,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时00分，Ocular Therapeutix, Inc.股票出现异动，股价大幅下跌5.12%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为10786.38%、5856.41%、421.82%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、216.61%、124.54%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140000189602632a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501140000189602632a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2502892469","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502892469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502892469?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:58","pubTimestamp":1736528337,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时58分，Ocular Therapeutix, Inc.股票出现波动，股价急速跳水5.07%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为1.78%。其相关个股中，Conduit Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Omniab Inc C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为1214.48%、806.15%、227.33%，振幅较大的相关个股有Lexaria Bioscience Corp C/Wts 14/01/2026 、Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为108.20%、100.85%、64.55%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111005858a21d301c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111005858a21d301c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocutx.com","stockEarnings":[{"period":"1week","weight":-0.1977},{"period":"1month","weight":0.0322},{"period":"3month","weight":-0.0674},{"period":"6month","weight":-0.364},{"period":"1year","weight":0.2089},{"period":"ytd","weight":-0.1733}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0606},{"period":"6month","weight":-0.0566},{"period":"1year","weight":0.0849},{"period":"ytd","weight":-0.0371}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocular Therapeutix, Inc.于2006年9月12号在特拉华州成立。该公司是一家生物制药公司，致力于通过开发和商业化针对眼部疾病和状况的创新疗法来提高人们的视力和生活质量，特别关注视网膜疾病。该公司基于水凝胶的生物可吸收候选产品的设计是给眼睛提供持续的治疗药物缓释。公司的主导候选产品是药物洗脱泪点塞OTX-DP和被插入到一个自然的开口叫坐落在靠近鼻子的眼睑的内侧部分的泪点OTX-TP。公司的泪小管栓候选产品结合了公司的水凝胶技术同美国食品和药物管理局，或FDA批准的治疗药物对眼睛提供持续给药目的。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.007929},{"month":2,"riseRate":0.727273,"avgChangeRate":0.225606},{"month":3,"riseRate":0.545455,"avgChangeRate":0.02622},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.035211},{"month":5,"riseRate":0.545455,"avgChangeRate":-0.00649},{"month":6,"riseRate":0.4,"avgChangeRate":0.015343},{"month":7,"riseRate":0.4,"avgChangeRate":-0.050859},{"month":8,"riseRate":0.545455,"avgChangeRate":0.0647},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.0952},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.083937},{"month":11,"riseRate":0.636364,"avgChangeRate":0.149248},{"month":12,"riseRate":0.454545,"avgChangeRate":0.068817}],"exchange":"NASDAQ","name":"Ocular Therapeutix","nameEN":"Ocular Therapeutix"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocular Therapeutix,OCUL,Ocular Therapeutix股票,Ocular Therapeutix股票老虎,Ocular Therapeutix股票老虎国际,Ocular Therapeutix行情,Ocular Therapeutix股票行情,Ocular Therapeutix股价,Ocular Therapeutix股市,Ocular Therapeutix股票价格,Ocular Therapeutix股票交易,Ocular Therapeutix股票购买,Ocular Therapeutix股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}